Mandate

VINGE ADVISES ANICURA IN CONJUNCTION WITH THE ACQUISITION OF VETERINÄRMOTTAGNING I NÄSUM

December 03, 2014

Vinge has advised AniCura in conjunction with its acquisition of the veterinary clinics, Veterinärmottagning i Näsum and its branch in Bromölla, which is located close to Kristianstad. The merger entails that the veterinary clinics have thereby gained a strong partner to assist in their future expansion efforts and at the same time AniCura has strengthened its position in southern Sweden. AniCura is a leader in advanced veterinary care for dogs, cats and other companion animals. The company was founded on the notion of combining resources to provide better veterinary care. Established in 2011, AniCura is the first merger of companion animal hospitals in the Nordic region, and is currently the only Nordic veterinary care group exclusively focused on companion animals.

Vinge’s team consisted of partner Jonas Bergström together with, among others, associates Gustav Jönsson and Ulrika Andersson.

Related

Vinge advises parts of the consortium in connection with the public takeover offer for Cint

The public takeover offer was announced by a consortium consisting of Triton Fund 6, Bolero, Patrick Comer and Brett Schnittlich. The offer values all shares in Cint at approximately SEK 1,989 million. The shares in Cint are listed on Nasdaq Stockholm, Mid Cap.
April 27, 2026

Nordea and SEB enters into a SEK 2,000,000,000 credit facility agreement

On 22 April 2026, Nordea and SEB entered into a credit facility agreement in the aggregate amount of SEK 2,000,000,000 (with an accordion option for an additional SEK 400,000,000) with Humble Group AB (publ).
April 27, 2026

Vinge has advised Northmill in connection with its inaugural issuance of primary capital instruments (AT1)

Vinge has advised Northmill Group AB in connection with its issuance of SEK 275 million primary capital instruments (so called “AT1 bonds”) with a floating rate interest of 3-month STIBOR + 690 basis points. The AT1 bonds are perpetual with a first call option after five years and are intended to be admitted to trading on Nasdaq Transfer Market and, subsequently, on Nasdaq Stockholm.
April 27, 2026